Wafik S. El-Deiry
Affiliations: | Biochemistry and Molecular Biophysics | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Oncology, PharmacyGoogle:
"Wafik El-Deiry"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Raymond D. Meng | grad student | 2001 | Penn |
| Nesrin Ozoren | grad student | 2002 | Penn |
| Earl R. McDonald | grad student | 2003 | Penn |
| Kyran O. Mitchell | grad student | 2003 | Penn |
| Joanna K. Sax | grad student | 2003 | Penn |
| Zhaoyu Jin | grad student | 2005 | Penn |
| Patrick A. Mayes | grad student | 2008 | Penn |
| Joshua E. Allen | grad student | 2012 | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Parker CS, Zhou L, Prabhu VV, et al. (2023) ONC201/TIC10 plus TLY012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor DR5 in gastric adenocarcinoma. American Journal of Cancer Research. 13: 6290-6312 |
| Chang WI, Honeyman JN, Zhang J, et al. (2023) Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors. American Journal of Cancer Research. 13: 6241-6255 |
| Tummala T, Sevilla Uruchurtu AS, Cruz A, et al. (2023) Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer. Current Oncology (Toronto, Ont.). 30: 9611-9626 |
| Carlsen L, Zhang S, Tian X, et al. (2023) The role of p53 in anti-tumor immunity and response to immunotherapy. Frontiers in Molecular Biosciences. 10: 1148389 |
| Huntington KE, Louie AD, Srinivasan PR, et al. (2023) GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. International Journal of Molecular Sciences. 24 |
| Vitale I, Pietrocola F, Guilbaud E, et al. (2023) Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death and Differentiation |
| Huntington KE, Louie AD, Srinivasan PR, et al. (2023) GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer. Biorxiv : the Preprint Server For Biology |
| Di Cristofano FR, Fong MW, Huntington KE, et al. (2023) Synergistic activity of ABT-263 and ONC201/TIC10 against solid tumor cell lines is associated with suppression of anti-apoptotic Mcl-1, BAG3, pAkt, and upregulation of pro-apoptotic Noxa and Bax cleavage during apoptosis. American Journal of Cancer Research. 13: 307-325 |
| Gonzalez Z, Carlsen L, El-Deiry WS. (2023) Temozolomide combined with ipilimumab plus nivolumab enhances T cell killing of MGMT-expressing, MSS colorectal cancer cells. American Journal of Cancer Research. 13: 216-226 |
| Zhang S, Carlsen L, Hernandez Borrero L, et al. (2022) Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer. Biomolecules. 12 |